期刊文献+

c-myc和c-fos的阳性表达与肝细胞癌发生的相关性研究 被引量:6

Correlation of proto-oncogene c-myc and c-fos expression with the occurrence of hepatocellular carcinoma
下载PDF
导出
摘要 目的:探讨c-myc和c-fos的阳性表达与肝细胞癌(HCC)发生的相互关系及临床意义。方法:运用免疫组化检测技术,分别检测肝癌组织、癌旁组织、正常肝脏组织中c-myc和c-fos编码蛋白的表达。结果:正常肝组织c-myc和c-fos均无阳性表达,而肝癌、癌旁组织均出现不同程度c-myc和c-fos表达。c-myc在癌组织表达率为51.43%(36/70),癌旁组织表达率为34.29%(24/70),c-fos在癌组织表达率为20.00%(14/70),癌旁组织表达率为7.14%(5/70),二者比较,差异具有统计学意义(P<0.05)。研究还发现,肝癌组织中c-myc和c-fos的表达存在相关性,一种基因的表达会导致另一种基因表达的升高。c-myc和c-fos癌基因的表达与HCC的发病年龄、性别、肿瘤大小无关,但与HCC的分化程度、UICC分期有关,差异具有统计学意义(P<0.05)。结论:癌基因c-myc、c-fos表达增强与HCC的发生、发展有密切关系。 Objective= To investigate the relationship between the positive expression of proto-on- cogene c-myc and c-los expression in the occurrence of hepatocellular carcinoma (HCC). Methods- Immu- nohistochemical detection techniques were used to detect expression of c-myc and c-los in hepatocellularcarcinoma tissues, adjacent tissues and normal liver tissues. Results. Positive expression of c-myc and c- los was detected in both carcinoma and adjacent tissues, but not in normal liver tissues. Ratio of c-myc ex- pression in hepatocellular carcinoma and adjacent tissues were 51.43~//00 (36/70) and 34.29~ (24/70). The proportion of c-los expression in hepatocellular carcinoma tissues and adjacent tissues were 20.00~ (14/ 70) and 7.14~ (5/70). It showed significant differences between two groups (P^0.05). The expression of c-myc and c-fos were closely related in the presence of hepatocellular carcinoma. Increased expression of one gene should result in elevated expression of the other. But the expression of c-myc and c-los oncogene was not related with patients age, gender and tumor size, it was correlated with the degree of differentia- tion of HCC and UICC stage (P%0.05). Conclusion: Increased expression of proto-oncogene c-myc and c- fos is correlated with the occurrence of live cancer.
出处 《海南医学院学报》 CAS 2014年第4期433-435,439,共4页 Journal of Hainan Medical University
基金 吴阶平基金(2010B10)~~
关键词 肝细胞癌 C-MYC C-FOS Hepatocellular carcinoma c myc c-fos
  • 相关文献

参考文献16

  • 1Ferlay J,Shin HR,Bray F. GLOBOCAN 2008[J].Cancer Incidence and Mortality Worldwide,2008,(3):34-36.
  • 2Chen JG,Zhang SW. Liver cancer epidemic in China:past,present and future[J].{H}Seminars in Cancer Biology,2011,(1):59-69.
  • 3吴飞翔,曹骥,赵荫农,苏建家,杨春,陈军,刘剑勇,欧超.B-myb C-myc在肝细胞性肝癌中的表达及临床意义[J].中国肿瘤临床,2008,35(5):269-271. 被引量:16
  • 4Beer S,Komatsubara K,Bellovin DI. Hepatotoxininduced changes in the adult murine liver promote MYC induced tumor-igenesis[J].PLoS One,2008,(6):98-101.
  • 5Szarewski A. HPV Vaccination and Cervical Cancer[J].{H}Current Oncology Reports,2012.100-103.
  • 6Uleberg KE,Munk AC,Skaland I. A protein profile study to discriminate CIN lesions from normal cervicalepithelium[J].{H}CELLULAR ONCOLOGY,2011,(5):443-450.
  • 7Svinareva LV,Glukhov AI,Moskaleva EY. Effect of modified DNA and RNA oligonucleotides on telomerase activity and tumor cell survival in vitro[J].Appl Biochem Micro,2011,(8):718-722.
  • 8Mendoza VD,Diaz CJ. Gene expression profile of cervical and skin tissues from human papillomavirus type 16 E6 transgenic mice[J].{H}BMC Cancer,2008,(1):347.
  • 9Verde P,Casalino L,Talotta F. Deciphering AP-1 function in tumorigenesis[J].{H}CELL CYCLE,2007,(21):2633-2639.
  • 10Malnou CE,Brockly F,Favard C. Heterodimerization with different Jun proteins controls c-Fos intranuclear dynamics and distribution[J].{H}Journal of Biological Chemistry,2010,(9):6552-6562.

二级参考文献19

  • 1王洛权,阚秀,吴秉铨.肝炎病毒与肝癌癌变的分子病理学进展[J].中华病理学杂志,1995,24(6):393-395. 被引量:13
  • 2朱波,欧超,罗元,曹骥,班克臣,焦杨,李瑗,苏建家.CyclinD1 c-myc和p53的表达与肝细胞癌生物学行为关系[J].中国肿瘤临床,2006,33(2):67-70. 被引量:12
  • 3徐标,韩春荣.槲皮素对血吸虫肝纤维化小鼠肝组织c-fos、c-jun mRNA和转化生长因子β1表达的抑制作用[J].中草药,2006,37(3):393-398. 被引量:4
  • 4Saville MK, Watson RJ. B-Myb: a key regulator of the cell cycle [J]. Adv Cancer Res, 1998, 72:109-140
  • 5Jonas JC, Laybutt DR, Steil GM, et al. High glucose stimulates early response gene c-Myc expression in rat pancreatic beta cells [J]. J Biol Chem, 2001, 276(38): 35375-35381
  • 6Fu M, Wang C, Li Z, et al. Minireview: Cyclin D1: normal and abnormal functions[J]. Endocrinology, 2004, 145(12): 5439-5447
  • 7Fields WR, Desiderio JG, Putnam KP, et al. Quantification of changes in c-myc mRNA levels in normal human bronchial epithelial (NHBE) and lung adenocarcinoma (A549)cells following chemical treatment [J]. Toxicol Sci, 2001, 63(1): 107-114
  • 8Cheng J, Luo J, Zhang X, et al. Inhibition of cell proliferation in HCC-0204 hepatoma cells by a c-myc specific fibozyme [J]. Cancer Gale Ther, 2000, 7(8): 407-412
  • 9Joaquin M, Watson RJ. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57^KIP2 by interacting with its cyclin-binding domain [J]. J Biol Chem, 2003, 278(45): 44255-44264
  • 10Raschella G, Cesi V, Amendola R, et al. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplificadon [J]. Cancer Res, 1999, 59 (14): 3365- 3368

共引文献15

同被引文献88

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部